Lapidus D, De León DD, Thornton PS, Hood D, Breit J, Raskin J, et al. The birth prevalence of congenital hyperinsulinism: a narrative review of the epidemiology of a rare disease. Horm Res Paediatr. 2024;17:1–8.

Google Scholar 

Yau D, Laver TW, Dastamani A, Senniappan S, Houghton JAL, Shaikh G, et al. Using referral rates for genetic testing to determine the incidence of a rare disease: the minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389. PLoS ONE. 2020;15(2):e0228417.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vajravelu ME, De León DD. Genetic characteristics of patients with congenital hyperinsulinism. Curr Opin Pediatr. 2018;30(4):568–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gϋemes M, Rahman SA, Kapoor RR, Flanagan S, Houghton JAL, Misra S, et al. Hyperinsulinemic hypoglycemia in children and adolescents: recent advances in understanding of pathophysiology and management. Rev Endocr Metab Disord. 2020;21(4):577–97.

Article  PubMed  PubMed Central  Google Scholar 

Avatapalle HB, Banerjee I, Shah S, Pryce M, Nicholson J, Rigby L, et al. Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism. Front Endocrinol (Lausanne). 2013;4:60.

Article  PubMed  Google Scholar 

Worth C, Yau D, Salomon Estebanez M, O’Shea E, Cosgrove K, Dunne M, et al. Complexities in the medical management of hypoglycaemia due to congenital hyperinsulinism. Clin Endocrinol (Oxf). 2020;92(5):387–95.

Article  PubMed  Google Scholar 

Güemes M, Rahman SA, Hussain K. What is a normal blood glucose? Arch Dis Child. 2016;101(6):569–74.

Article  PubMed  Google Scholar 

Shaikh MG, Lucas-Herald AK, Dastamani A, Salomon Estebanez M, Senniappan S, Abid N, et al. Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus. Front Endocrinol (Lausanne). 2023;14:1231043.

Article  PubMed  Google Scholar 

De Leon DD, Arnoux JB, Banerjee I, Bergada I, Bhatti T, Conwell LS, et al. International guidelines for the diagnosis and management of hyperinsulinism. Horm Res Paediatr. 2023;97(3):279–98.

Article  PubMed  Google Scholar 

Hewat TI, Johnson MB, Flanagan SE. Congenital hyperinsulinism: current laboratory-based approaches to the genetic diagnosis of a heterogeneous disease. Front Endocrinol (Lausanne). 2022;13:873254.

Article  PubMed  Google Scholar 

Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol. 2013;168(4):557–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Larsen AR, Brusgaard K, Christesen HT, Detlefsen S. Genotype-histotype-phenotype correlations in hyperinsulinemic hypoglycemia. Histol Histopathol. 2024;39(7):817–44.

CAS  PubMed  Google Scholar 

James C, Kapoor RR, Ismail D, Hussain K. The genetic basis of congenital hyperinsulinism. J Med Genet. 2009;46(5):289–99.

Article  CAS  PubMed  Google Scholar 

Galcheva S, Al-Khawaga S, Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycaemia. Best Pract Res Clin Endocrinol Metab. 2018;32(4):551–73.

Article  CAS  PubMed  Google Scholar 

Thornton PS, Stanley CA, De Leon DD. Congenital hyperinsulinism: an historical perspective. Horm Res Paediatr. 2022;95(6):631–7.

Article  CAS  PubMed  Google Scholar 

Boss M, Rottenburger C, Brenner W, Blankenstein O, Prasad V, Prasad S, et al. 68Ga-NODAGA-Exendin-4 PET/CT improves the detection of focal congenital hyperinsulinism. J Nucl Med. 2022;63(2):310–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casertano A, De Matteis A, Mozzillo E, Rosanio FM, Buono P, Fattorusso V, et al. Diagnosis of congenital hyperinsulinism can occur not only in infancy but also in later age: a new flow chart from a single center experience. Ital J Pediatr. 2020;46(1):131.

Article  PubMed  PubMed Central  Google Scholar 

Demirbilek H, Hussain K. Congenital hyperinsulinism: diagnosis and treatment update. J Clin Res Pediatr Endocrinol. 2017;30(9):69–87.

Google Scholar 

Helleskov A, Melikyan M, Globa E, Shcherderkina I, Poertner F, Larsen AM, et al. Both low blood glucose and insufficient treatment confer risk of neurodevelopmental impairment in congenital hyperinsulinism: a multinational cohort study. Front Endocrinol (Lausanne). 2017. https://doi.org/10.3389/fendo.2017.00156.

Article  PubMed  Google Scholar 

Al-Otaibi H, Senniappan S, Alam S, Hussain K. Biochemical studies in patients with hyperinsulinaemic hypoglycaemia. Eur J Pediatr. 2013;172(11):1435–40.

Article  CAS  PubMed  Google Scholar 

Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167(2):238–45.

Article  PubMed  PubMed Central  Google Scholar 

Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Investig. 2005;115(8):2047–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Black J. Diazoxide and the treatment of hypoglycemia: an historical review. Ann N Y Acad Sci. 1968;150(2):194–203.

Article  CAS  PubMed  Google Scholar 

Ng AYL, Agrawal P, Vijayan R, Arya VB, Kapoor RR, Shah P. Low-dose diazoxide therapy in hyperinsulinaemic hypoglycaemia. Clin Endocrinol (Oxf). 2024;100(2):140–2.

Article  CAS  PubMed  Google Scholar 

Malhotra N, Yau D, Cunjamalay A, Gunasekara B, Athanasakopoulou S, Gilbert C, et al. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism. Clin Endocrinol (Oxf). 2024;100(2):132–7.

Article  CAS  PubMed  Google Scholar 

Kizu R, Nishimura K, Sato R, Kosaki K, Tanaka T, Tanigawara Y, et al. Population pharmacokinetics of diazoxide in children with hyperinsulinemic hypoglycemia. Horm Res Paediatr. 2017;88(5):316–23.

Article  CAS  PubMed  Google Scholar 

Chen SC, Dastamani A, Pintus D, Yau D, Aftab S, Bath L, et al. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: recommendations from a multicentre study in the United Kingdom. Clin Endocrinol (Oxf). 2019;91(6):770–5.

Article  CAS  PubMed  Google Scholar 

Prado LA, Castro M, Weisz DE, Jain A, Belik J. Necrotising enterocolitis in newborns receiving diazoxide. Arch Dis Child Fetal Neonatal Ed. 2021;106(3):F306–10.

Article  Google Scholar 

Chen X, Feng L, Yao H, Yang L, Qin Y. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: a systematic review and meta-analysis. PLoS ONE. 2021;16(2):e0246463.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herrera A, Vajravelu ME, De León DD. Prevalence of adverse events in children with congenital hyperinsulinism treated with diazoxide. J Clin Endocrinol Metab. 2018;103(12):4365–72.

Article  PubMed  PubMed Central  Google Scholar 

van Albada ME, Mohnike K, Dunne MJ, Banerjee I, Betz SF. Somatostatin receptors in congenital hyperinsulinism: biology to bedside. Front Endocrinol (Lausanne). 2022;27:13.

Google Scholar 

Haris B, Saraswathi S, Hussain K. Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia. Ther Adv Endocrinol Metab. 2020. https://doi.org/10.1177/2042018820965068.

Article  PubMed  PubMed Central  Google Scholar 

Hosokawa Y, Kawakita R, Yokoya S, Ogata T, Ozono K, Arisaka O, et al. Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry. Endocr J. 2017;64(9):867–80.